Rare inborn errors associated with chronic hepatitis B virus infection

Area of Science:

• Genetics
• Hepatology
• Immunology

Background:

• Chronic hepatitis B (CHB) is a significant global health concern.
• The influence of rare genetic variations on CHB development remains largely uninvestigated.
• Identifying genetic predispositions can offer insights into disease mechanisms and potential therapeutic targets.

Purpose of the Study:

• To identify rare genetic variants that may predispose individuals to CHB.
• To investigate the association between specific genetic mutations and CHB susceptibility.
• To explore the expression patterns of a key associated gene in liver tissues.

Main Methods:

• Exome sequencing was performed on CHB patients without identifiable risk factors and healthy controls.
• Six rare variant alleles were selected for follow-up association studies using Sanger sequencing.
• Case-control studies involved 1,728 CHB patients and 1,636 healthy controls.
• Immunohistochemistry, real-time PCR, and western blotting were used to analyze gene expression.

Main Results:

• Four missense mutations in transmembrane protein 2, interferon alpha 2, NLR family member X1, and complement component 2 were significantly associated with CHB.
• Associated variants showed strong statistical significance (P < 1.0 × 10(-7) to 2.78 × 10(-4)) with increased odds ratios.
• Transmembrane protein 2 expression was reduced in CHB liver tissues and HBV-infected cells compared to healthy controls.

Conclusions:

• The study identified four missense mutations linked to an increased risk of developing CHB.
• These findings provide evidence for rare, inborn genetic defects contributing to host susceptibility to CHB.
• The reduced expression of transmembrane protein 2 in CHB suggests a potential role in disease pathogenesis.